Perennial Allergic Rhinitis
71
2
2
60
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Published Results
33 trials with published results (46%)
Research Maturity
60 completed trials (85% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
2.8%
2 terminated out of 71 trials
96.8%
+10.3% vs benchmark
75%
53 trials in Phase 3/4
55%
33 of 60 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 60 completed trials
Clinical Trials (71)
The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy
Trial of JYB1904 Injection in Patients With Perennial Allergic Rhinitis
The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis
A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis
A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis
Investigation of the Effects of a Multispecies Probiotic Formulation on Perennial Allergic Rhinitis
Bioequivalence Study of AJU-R713 and R713R in Healthy Adult Volunteers
As Needed Versus Regular Intranasal Corticosteroid in Children With Perennial Allergic Rhinitis
Efficacy and Safety of AM-301 on Allergic Symptoms of Perennial Allergic Rhinitis Sufferers
A Long-term Study of Mometasone Furoate in Patients With Perennial Allergic Rhinitis (Study P04459)
Study of the Safety and Pharmacokinetics of Montelukast (MK-0476) in the Treatment of Japanese Pediatric Participants With Perennial Allergic Rhinitis (MK-0476-520)
A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200)
The Effects of Mometasone Furoate Nasal Spray in Subjects With Sleep-disordered Breathing (SDB) Associated With Perennial Allergic Rhinitis (Study P04726)
Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spray and Dymista Nasal Spray
Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis
Effects of Pine Cone Extract on Serum IgE Levels in Perennial Rhinitis
Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis
Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03182)
Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03180)
Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03181)